Amber Scorah | 05/31/2011
The role of CROs in the drug discovery process is constantly evolving, and as data management and distribution efforts improve, there is increased opportunity for leveraging CROs within Drug Discovery research.
In this podcast, Rose Gonzales, Director at Pfizer, talks about the ever changing role of CROs, and the evolving relationship between CROs and CMI.
Have Your Say
Rate this feature and give us your feedback in the comments section below...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More